| Rheumatoid Arthritis |
1 |
1 |
| Systemic Lupus Erythematosus |
0 |
0.75 |
| Lupus |
0 |
0.8 |
| Dermatitis |
0 |
0.53 |
| Lupus Nephritis |
0 |
0.9 |
| California |
0 |
0.34 |
| Dermatoses |
0 |
0.34 |
| Pregnancy |
0 |
0.34 |
| COVID-19 |
0 |
0.3 |
| Autoimmune Disease |
0 |
0.27 |
| Jobs |
0 |
0.27 |
| Pandemic |
0 |
0.27 |
| Tissue |
0 |
0.27 |
| Junior Doctors |
0 |
0.24 |
| Social Determinants of Health |
0 |
0.22 |
| Arthritis |
0 |
0.95 |
| Genomic Medicine |
0 |
0.19 |
| Renal Failure |
0 |
0.15 |
| Acute Kidney Injury |
0 |
0.14 |
| Wound Management |
0 |
0.14 |
| Genetics |
0 |
0.13 |
| Grant |
0 |
0.13 |
| Racism |
0 |
0.13 |
| Atopic Dermatitis |
0 |
0.07 |
| Biomarker |
0 |
0.07 |
| Blood |
0 |
0.07 |
| Cancer |
0 |
0.07 |
| Child |
0 |
0.07 |
| Diversity |
0 |
0.07 |
| Ear |
0 |
0.07 |
| Epidemiology |
0 |
0.07 |
| Fellowship |
0 |
0.07 |
| Financial Reimbursement |
0 |
0.07 |
| Immunology |
0 |
0.07 |
| Injury |
0 |
0.07 |
| Kidney |
0 |
0.07 |
| Nephritis |
0 |
0.07 |
| Peer Review |
0 |
0.07 |
| Professional Development |
0 |
0.07 |
| Psoriasis |
0 |
0.85 |
| Revenue and Practice Management |
0 |
0.07 |
| Scar |
0 |
0.07 |
| Skin Lesion |
0 |
0.07 |
| Students |
0 |
0.07 |
| Topical Therapy |
0 |
0.07 |
| Wound |
0 |
0.07 |